Clinical preferences and trends of anti-vascular endothelial growth factor treatments for diabetic macular edema in Japan

Masahiko Sugimoto,Hideyuki Tsukitome,Fumiki Okamoto,Tetsuro Oshika,Tetsuo Ueda,Masanori Niki,Yoshinori Mitamura,Hiroto Ishikawa,Fumi Gomi,Shigehiko Kitano,Hidetaka Noma,Masahiko Shimura,Shozo Sonoda,Osamu Sawada,Masahito Ohji,Kozo Harimoto,Masaru Takeuchi,Yoshihiro Takamura,Mineo Kondo,Taiji Sakamoto

Clinical preferences and trends of anti-vascular endothelial growth factor treatments for diabetic macular edema in Japan

2019

Aims/Introduction To determine the current clinical preferences of anti‐vascular endothelial growth factor (VEGF) treatment protocols for diabetic macular edema (DME) in Japan.

Keywords:

Endocrinology
Internal medicine
Diabetes mellitus
Macular edema
Vascular endothelial growth factor
Medicine
Ranibizumab
Combination therapy
Regimen
Pro re nata
Aflibercept
Ophthalmology
Visual acuity
Cerebral infarction

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations